Corcept Therapeutics
CORT
CORT
273 hedge funds and large institutions have $2.79B invested in Corcept Therapeutics in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 82 increasing their positions, 93 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
273
Holders Change
+28
Holders Change %
+11.43%
% of All Funds
4%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
56
Increased
82
Reduced
93
Closed
25
Calls
$49.6M
Puts
$40.6M
Net Calls
+$8.97M
Net Calls Change
+$3.99M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$84.2M |
| 2 |
BlackRock
New York
|
$533M |
| 3 |
Man Group
London,
United Kingdom
|
$26.8M |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
$15.2M |
| 5 |
QC
Quantedge Capital
Singapore
|
$8.07M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
$78.3M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
$10.1M |
| 3 |
Cerity Partners
New York
|
$2.41M |
| 4 |
Invesco
Atlanta,
Georgia
|
$22M |
| 5 |
Northern Trust
Chicago,
Illinois
|
$35.5M |
